Company Overview
| Stock Name | Rainmed-B |
|---|---|
| Stock Code | 02297 |
| Company Full Name | To be extracted |
| Industry | 醫療保健 |
| Principal Activities | 主要在中國、歐洲及其他地區從事基於冠狀動脈造影的血流儲備分數（caFFR）系統及基於冠狀動脈造影的微血管阻力指數（caIMR）系統相關醫療器械的研發、制造及商業化。 |
| Listing Date | 2022-07-08 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | To be extracted |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 中國江蘇省蘇州市蘇州工業園區金雞湖大道99號東北區31棟 |
| Business Address (Hong Kong) | To be extracted |
| Place of Incorporation | To be extracted |
| Listing Method | To be extracted |
| Listing Board | Main Board |
| Website | https://www.rainmed.com/ |
| Share Registrar | 卓佳证券登记有限公司 (Tricor Investor Services Limited) |
| Registrar Contact | (852)2980 1333 |
| A-Share/US Dual Listing | No data |
Offering Information
| Offering Mechanism | To be extracted |
|---|---|
| Offer Price | HK$ 6.24 / shares |
| Offer Price Range | To be extracted |
| Lot Size | To be extracted |
| Entry Threshold | To be extracted |
| Par Value | To be extracted |
| Offer Period | To be extracted |
| Global Offering Shares | To be extracted |
| HK Public Offer Shares (Initial) | To be extracted |
| Public Offer Lots (Initial) | To be extracted |
| International Placing Shares (Initial) | To be extracted |
| Offer Ratio | To be extracted |
| Total Shares Post-IPO | To be extracted |
| Greenshoe (Over-allotment Option) | To be confirmed |
| Stabilizing Manager (Greenshoe) | — |
| Cornerstone Share | No cornerstone investors |
| Clawback Tiers | To be extracted |
| Reallocation Option | To be confirmed |
| Total Global Offering Size | HK$ 14,576,640 |
Stock Connect Inclusion
| HK Market Cap | --- |
|---|
| 26Q2 Regular Review | |
| Inclusion Pathway | None |
|---|---|
| Est. Threshold | --- |
| Analysis Result | 无法确定入通路径 |
Valuation & Financials
| Market Cap (at Offer Price) | To be extracted |
|---|---|
| Pre-IPO Valuation (Last Round) | Not disclosed |
| P/E Ratio | Not disclosed |
| Profit/Loss Status | To be extracted |
| Period-End Cash Balance | To be extracted |
| Listing Expenses | To be extracted |
| Listing Expenses / Funds Raised | To be extracted |
| Total Pre-IPO Investment | To be extracted |
First Day Performance
| First Day Close | HK$ 5.28 |
|---|---|
| First Day Open | HK$ 5.6 |
| First Day Change | -15.38% |
| First Day Volume | 5633000.0 |
| First Day Turnover | 32209800.0 |
Use of Proceeds
| Use of Proceeds | 1、80.0%或約63.1百萬港元將撥作我們的核心產品caFFR系統及caIMR系統； 2、16.5%或約13.2百萬港元將撥作其他管線產品的持續研發、生產及商業化的資金； 3、3.5%或約2.7百萬港元將撥作一般營運資金及一般公司用途。 |
|---|
Underwriting Syndicate
Sole Sponsor (1)
Huatai Financial Holdings (Hong Kong) Limited CE AOK809
Overall Coordinators (1)
Huatai Financial Holdings (Hong Kong) Limited CE AOK809
Joint Bookrunners (4)
Joint Lead Managers (5)
Cornerstone Investors
This stock has no cornerstone investors.
Directors & Management
| Chairman | 霍云飛 |
|---|---|
| Company Secretary | 張亮;朱卓婷 |
No director data available.
Major Shareholders
| Major Shareholders & Holdings | 霍云飛(18.39%);霍云龍(13.70%);中國平安保險(集團)股份有限公司(10.28%);上海同襄灝乾企業管理合夥企業(有限合夥)(8.58%);周彬(7.09%);河北東拓投資有限公司(5.12%) |
|---|
